Search research articles
Contact Us
Filters
Showing results (11-20 of 118) with videos related to
Page
of 12
Sort By:
Investigational New Drugs
|
November 29, 2008
Bortezomib treatment of ovarian cancer cells mediates endoplasmic reticulum stress, cell cycle arrest, and apoptosis
Ansgar Brüning, Petra Burger, Marianne Vogel, et al.
Clinical Chemistry and Laboratory Medicine
|
October 25, 2012
Human epididymis protein 4 (HE4) in benign and malignant diseases
Linda Hertlein, Petra Stieber, Angela Kirschenhofer, et al.
Clinical Chemistry and Laboratory Medicine
|
May 9, 2007
Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours
Miriam Lenhard, Caroline Kuemper, Nina Ditsch, et al.
Journal of Visualized Experiments : Jove
|
March 11, 2024
Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages
Fabian Trillsch, Juliane Reichenbach, Bastian Czogalla, et al.
Archives of Gynecology and Obstetrics
|
February 25, 2010
Cetuximab monotherapy in advanced cervical cancer: a retrospective study with five patients
Linda Hertlein, Miriam Lenhard, Angela Kirschenhofer, et al.
Gynecologic Oncology
|
October 4, 2005
Impact of age on outcome in patients with advanced ovarian cancer treated within a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)
Pauline Wimberger, Nils Lehmann, Rainer Kimmig, et al.
Cancer Biology & Therapy
|
December 25, 2008
Nelfinavir induces the unfolded protein response in ovarian cancer cells, resulting in ER vacuolization, cell cycle retardation and apoptosis
Ansgar Brüning, Petra Burger, Marianne Vogel, et al.
Biochemical and Biophysical Research Communications
|
November 13, 2008
Nelfinavir induces TRAIL receptor upregulation in ovarian cancer cells
Ansgar Brüning, Marianne Vogel, Petra Burger, et al.
Archives of Gynecology and Obstetrics
|
July 30, 2009
Prognostic significance of estrogen receptor alpha and beta expression in human serous carcinomas of the ovary
Alexander Burges, Ansgar Brüning, Christine Dannenmann, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
May 30, 2009
Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort
Miriam S Lenhard, Stefanie Mitterer, Carolin Kümper, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 118) with videos related to
Sort By:
Page
of 12
Investigational New Drugs
|
November 29, 2008
Bortezomib treatment of ovarian cancer cells mediates endoplasmic reticulum stress, cell cycle arrest, and apoptosis
Ansgar Brüning, Petra Burger, Marianne Vogel, et al.
Clinical Chemistry and Laboratory Medicine
|
October 25, 2012
Human epididymis protein 4 (HE4) in benign and malignant diseases
Linda Hertlein, Petra Stieber, Angela Kirschenhofer, et al.
Clinical Chemistry and Laboratory Medicine
|
May 9, 2007
Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours
Miriam Lenhard, Caroline Kuemper, Nina Ditsch, et al.
Journal of Visualized Experiments : Jove
|
March 11, 2024
Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages
Fabian Trillsch, Juliane Reichenbach, Bastian Czogalla, et al.
Archives of Gynecology and Obstetrics
|
February 25, 2010
Cetuximab monotherapy in advanced cervical cancer: a retrospective study with five patients
Linda Hertlein, Miriam Lenhard, Angela Kirschenhofer, et al.
Gynecologic Oncology
|
October 4, 2005
Impact of age on outcome in patients with advanced ovarian cancer treated within a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)
Pauline Wimberger, Nils Lehmann, Rainer Kimmig, et al.
Cancer Biology & Therapy
|
December 25, 2008
Nelfinavir induces the unfolded protein response in ovarian cancer cells, resulting in ER vacuolization, cell cycle retardation and apoptosis
Ansgar Brüning, Petra Burger, Marianne Vogel, et al.
Biochemical and Biophysical Research Communications
|
November 13, 2008
Nelfinavir induces TRAIL receptor upregulation in ovarian cancer cells
Ansgar Brüning, Marianne Vogel, Petra Burger, et al.
Archives of Gynecology and Obstetrics
|
July 30, 2009
Prognostic significance of estrogen receptor alpha and beta expression in human serous carcinomas of the ovary
Alexander Burges, Ansgar Brüning, Christine Dannenmann, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
May 30, 2009
Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort
Miriam S Lenhard, Stefanie Mitterer, Carolin Kümper, et al.
Page
of 12